Literature DB >> 25164924

Mutations associated with occult hepatitis B in HIV-positive South Africans.

Eleanor A Powell1, Maemu P Gededzha, Michael Rentz, Nare J Rakgole, Selokela G Selabe, Tebogo A Seleise, M Jeffrey Mphahlele, Jason T Blackard.   

Abstract

Occult hepatitis B is characterized by the absence of hepatitis B surface antigen (HBsAg) but the presence of HBV DNA. Because diagnosis of hepatitis B virus (HBV) typically includes HBsAg detection, occult HBV remains largely undiagnosed. Occult HBV is associated with increased risk of hepatocellular carcinoma, reactivation to chronic HBV during immune suppression, and transmission during blood transfusion and liver transplant. The mechanisms leading to occult HBV infection are unclear, although viral mutations are likely a significant factor. In this study, sera from 394 HIV-positive South Africans were tested for HBV DNA and HBsAg. For patients with detectable HBV DNA, the overlapping surface and polymerase open reading frames (ORFs) were sequenced. Occult-associated mutations-those mutations found exclusively in individuals with occult HBV infection but not in individuals with chronic HBV infection from the same cohort or GenBank references-were identified. Ninety patients (22.8%) had detectable HBV DNA. Of these, 37 had detectable HBsAg, while 53 lacked detectable surface antigen. The surface and polymerase ORFs were cloned successfully for 19 patients with chronic HBV and 30 patients with occult HBV. In total, 235 occult-associated mutations were identified. Ten occult-associated mutations were identified in more than one patient. Additionally, 15 amino acid positions had two distinct occult-associated mutations at the same residue. Occult-associated mutations were common and present in all regions of the surface and polymerase ORFs. Further study is underway to determine the effects of these mutations on viral replication and surface antigen expression in vitro.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HBV polymerase; HBV surface antigen; HBV/HIV co-infection; immune selection; occult hepatitis B virus

Mesh:

Substances:

Year:  2014        PMID: 25164924      PMCID: PMC4562318          DOI: 10.1002/jmv.24057

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  79 in total

1.  Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection.

Authors:  M Schories; T Peters; J Rasenack
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

2.  Evolution of cytotoxic T-lymphocyte epitopes in hepatitis B virus.

Authors:  Kristi M Westover; Austin L Hughes
Journal:  Infect Genet Evol       Date:  2006-11-30       Impact factor: 3.342

3.  Assessment of CXCL12 (SDF-1α) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran.

Authors:  Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi; Hossein Khoramdelazad; Narges Yaghini; Ebrahim Rezazadeh Zarandi
Journal:  Arch Med Res       Date:  2010-07       Impact factor: 2.235

4.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.

Authors:  K Pogány; H L Zaaijer; J M Prins; F W Wit; J M A Lange; M G H M Beld
Journal:  AIDS Res Hum Retroviruses       Date:  2005-11       Impact factor: 2.205

6.  Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; Cheuk-Kwong Lee; Yasuhito Tanaka; Jean-Pierre Allain; James Fung; Jennifer Leung; Che-Kit Lin; Masaya Sugiyama; Fuminaka Sugauchi; Masashi Mizokami; Ching-Lung Lai
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

7.  Prevalence of occult hepatitis B virus infection in a general adult population in Korea.

Authors:  Eun Young Song; Yeo Min Yun; Myoung Hee Park; Dong Hee Seo
Journal:  Intervirology       Date:  2009-04-25       Impact factor: 1.763

8.  Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.

Authors:  Azwidowi Lukhwareni; Rosemary J Burnett; S Gloria Selabe; M Olga Mzileni; M Jeffrey Mphahlele
Journal:  J Med Virol       Date:  2009-03       Impact factor: 2.327

9.  Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.

Authors:  H L Zaaijer; P Torres; A Ontañón; L González Ponte; M H G M Koppelman; P N Lelie; F J van Hemert; H J Boot
Journal:  J Med Virol       Date:  2008-08       Impact factor: 2.327

10.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more
  11 in total

Review 1.  Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Authors:  Jason T Blackard; Kenneth E Sherman
Journal:  Rev Med Virol       Date:  2018-05-15       Impact factor: 6.989

2.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

3.  Molecular characterization of hepatitis B virus X gene in HIV-positive South Africans.

Authors:  Maemu P Gededzha; Tsakani H Sondlane; Lesibana A Malinga; Rosemary J Burnett; Ramokone L Lebelo; Jason T Blackard; M Jeffrey Mphahlele; Selokela G Selabe
Journal:  Virus Genes       Date:  2018-02-06       Impact factor: 2.332

Review 4.  Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?

Authors:  Caitlin Pley; José Lourenço; Anna L McNaughton; Philippa C Matthews
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

5.  High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.

Authors:  Kathleen Ryan; Motswedi Anderson; Ivayla Gyurova; Lilliam Ambroggio; Sikhulile Moyo; Teresa Sebunya; Joseph Makhema; Richard Marlink; Max Essex; Rosemary Musonda; Simani Gaseitsiwe; Jason T Blackard
Journal:  Open Forum Infect Dis       Date:  2017-09-13       Impact factor: 3.835

6.  In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Authors:  Motswedi Anderson; Wonderful T Choga; Sikhulile Moyo; Trevor Graham Bell; Tshepiso Mbangiwa; Bonolo B Phinius; Lynette Bhebhe; Theresa K Sebunya; Joseph Makhema; Richard Marlink; Anna Kramvis; Max Essex; Rosemary M Musonda; Jason T Blackard; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

7.  Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.

Authors:  Jianhong Chen; Yan Liu; Jun Zhao; Zhihui Xu; Rongjuan Chen; Lanlan Si; Shanshan Lu; Xiaodong Li; Shuai Wang; Kai Zhang; Jin Li; Juqiang Han; Dongping Xu
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

8.  Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.

Authors:  Tshepiso Mbangiwa; Ishmael Kasvosve; Motswedi Anderson; Prisca K Thami; Wonderful T Choga; Austen Needleman; Bonolo B Phinius; Sikhulile Moyo; Melvin Leteane; Jean Leidner; Jason T Blackard; Gloria Mayondi; Betsy Kammerer; Rosemary M Musonda; Max Essex; Shahin Lockman; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-05-17       Impact factor: 4.096

9.  Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Authors:  Motswedi Anderson; Wonderful Tatenda Choga; Sikhulile Moyo; Trevor Graham Bell; Tshepiso Mbangiwa; Bonolo Bonita Phinius; Lynnette Bhebhe; Theresa Kibirige Sebunya; Shahin Lockman; Richard Marlink; Anna Kramvis; Max Essex; Rosemary Mubanga Musonda; Jason Tory Blackard; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-09-07       Impact factor: 4.096

10.  A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.

Authors:  Jolynne Mokaya; Anna L McNaughton; Martin J Hadley; Apostolos Beloukas; Anna-Maria Geretti; Dominique Goedhals; Philippa C Matthews
Journal:  PLoS Negl Trop Dis       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.